During recent NVLX meetings, particular emphasis

During recent NVLX meetings, particular emphasis was placed on progress in preparing for the late-phase clinical trials of Nuvilex that will use the recently acquired cellulose-based live-cell encapsulation Cell-in-a-Box™ technology as part of the treatment for those suffering from advanced, inoperable pancreatic cancer. In addition, plans for developing treatments for diabetes that use the same technology were discussed in detail. Additional points of discussion were the objectives and plans for development of treatments for cancer and other diseases using active compounds derived from marijuana and the potential role that the live-cell encapsulation technology might be able to play in such treatments.